Edmund Dunn - Net Worth and Insider Trading
Edmund Dunn Net Worth
The estimated net worth of Edmund Dunn is at least $100,676 dollars as of 2024-12-26. Edmund Dunn is the Principal Accounting Officer of Monte Rosa Therapeutics Inc and owns about 13,944 shares of Monte Rosa Therapeutics Inc (GLUE) stock worth over $100,676. Details can be seen in Edmund Dunn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edmund Dunn has not made any transactions after 2024-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Edmund Dunn
Edmund Dunn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edmund Dunn owns 1 companies in total, including Monte Rosa Therapeutics Inc (GLUE) .
Click here to see the complete history of Edmund Dunn’s form 4 insider trades.
Insider Ownership Summary of Edmund Dunn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GLUE | Monte Rosa Therapeutics Inc | 2024-07-05 | Principal Accounting Officer |
Edmund Dunn Latest Holdings Summary
Edmund Dunn currently owns a total of 1 stock. Edmund Dunn owns 13,944 shares of Monte Rosa Therapeutics Inc (GLUE) as of July 5, 2024, with a value of $100,676.
Latest Holdings of Edmund Dunn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics Inc | 2024-07-05 | 13,944 | 7.22 | 100,676 |
Holding Weightings of Edmund Dunn
Edmund Dunn Form 4 Trading Tracker
According to the SEC Form 4 filings, Edmund Dunn has made a total of 2 transactions in Monte Rosa Therapeutics Inc (GLUE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Monte Rosa Therapeutics Inc is the sale of 1,610 shares on July 5, 2024, which brought Edmund Dunn around $6,166.
Insider Trading History of Edmund Dunn
- 1
Edmund Dunn Trading Performance
Edmund Dunn Ownership Network
Edmund Dunn Owned Company Details
What does Monte Rosa Therapeutics Inc do?
Who are the key executives at Monte Rosa Therapeutics Inc?
Edmund Dunn is the Principal Accounting Officer of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , General Counsel Philip Nickson , and Chief Business Officer Julian G Jones .
Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary
Over the past 18 months, Edmund Dunn made 2 insider transaction in Monte Rosa Therapeutics Inc (GLUE) with a net sale of 2,817. Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. ,
In summary, during the past 3 months, insiders sold 157,895 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 157,895 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,860,491 shares.
Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monte Rosa Therapeutics Inc Insider Transactions
Edmund Dunn Mailing Address
Above is the net worth, insider trading, and ownership report for Edmund Dunn. You might contact Edmund Dunn via mailing address: Monte Rosa Therapeutics, Inc., 321 Harrison Avenue, Suite 900, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
